Image

Stryker Corporation (SYK) Q2 2025 Earnings Call Transcript

Stryker Corporation (NYSE:SYK) Q2 2025 Earnings Conference Call July 31, 2025 4:30 PM ET

Company Participants

Jason Beach – Vice President of Finance & Investor Relations
Kevin A. Lobo – Chairman, CEO & President
Preston Wells – VP & CFO

Conference Call Participants

Caitlin Cronin – Canaccord Genuity Corp., Research Division
Christopher Thomas Pasquale – Nephron Research LLC
Danielle Joy Antalffy – UBS Investment Bank, Research Division
Joanne Karen Wuensch – Citigroup Inc., Research Division
Lawrence H. Biegelsen – Wells Fargo Securities, LLC, Research Division
Matthew Charles Taylor – Jefferies LLC, Research Division
Matthew Oliver O’Brien – Piper Sandler & Co., Research Division
Matthew Stephan Miksic – Barclays Bank PLC, Research Division
Michael Stephen Matson – Needham & Company, LLC, Research Division
Philip Chickering – Deutsche Bank AG, Research Division
Richard Samuel Newitter – Truist Securities, Inc., Research Division
Robert Justin Marcus – JPMorgan Chase & Co, Research Division
Ryan Benjamin Zimmerman – BTIG, LLC, Research Division
Shagun Singh Chadha – RBC Capital Markets, Research Division
Steven Michael Lichtman – Oppenheimer & Co. Inc., Research Division
Travis Lee Steed – BofA Securities, Research Division
Vijay Muniyappa Kumar – Evercore ISI Institutional Equities, Research Division

Operator

Welcome to the Second Quarter 2025 Stryker Earnings Call. My name is Megan, and I’ll be your operator for today’s call. [Operator Instructions] This conference call is being recorded for replay purposes.

Before we begin, I would like to remind you that the discussions during this conference call will include forward-looking statements. Factors that could cause actual results to differ materially are discussed in the company’s most recent filings with the SEC. Also, the discussions will include certain non-GAAP financial measures. Reconciliations to the most directly comparable GAAP financial measures can be found in today’s press release that is an exhibit to Stryker’s current report on Form 8-K filed today

SHARE THIS POST